These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20101822)

  • 1. Subpopulations of tumor-infiltrating lymphocytes in ovarian serous adenocarcinoma.
    Kairbayeva MZ; Zueva EV; Mozhenkova AV; Kokosadze NV; Nikogosyan SO; Tupitsyn NN
    Dokl Biochem Biophys; 2009; 429():289-92. PubMed ID: 20101822
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor-infiltrating lymphocytes expressing the tissue resident memory marker CD103 are associated with increased survival in high-grade serous ovarian cancer.
    Webb JR; Milne K; Watson P; Deleeuw RJ; Nelson BH
    Clin Cancer Res; 2014 Jan; 20(2):434-44. PubMed ID: 24190978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of T lymphocytes infiltrating peritoneal metastases in advanced ovarian cancer: associations with vascular endothelial growth factor levels and prognosis in patients receiving platinum-based chemotherapy.
    Tsiatas ML; Gyftaki R; Liacos C; Politi E; Rodolakis A; Dimopoulos MA; Bamias A
    Int J Gynecol Cancer; 2009 Nov; 19(8):1329-34. PubMed ID: 20009885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PD-L1 expression on stromal tumor-infiltrating lymphocytes is a favorable prognostic factor in ovarian serous carcinoma.
    Kim KH; Choi KU; Kim A; Lee SJ; Lee JH; Suh DS; Kwon BS; Hwang C
    J Ovarian Res; 2019 Jun; 12(1):56. PubMed ID: 31208449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Favorable prognostic impact of Natural Killer cells and T cells in high-grade serous ovarian carcinoma.
    Henriksen JR; Donskov F; Waldstrøm M; Jakobsen A; Hjortkjaer M; Petersen CB; Dahl Steffensen K
    Acta Oncol; 2020 Jun; 59(6):652-659. PubMed ID: 31931651
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunological peculiarities of CD-56-positive serous ovarian adenocarcinoma.
    Zueva EV; Kairbayeva MZ; Nikogosyan SO; Mozhenkova AV; Digaeva MA; Tereshkina IV; Tupitsyn NN
    Bull Exp Biol Med; 2010 Oct; 149(5):604-8. PubMed ID: 21165398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor cytolysis by lymphocytes infiltrating ovarian malignant ascites.
    Ioannides CG; Platsoucas CD; Rashed S; Wharton JT; Edwards CL; Freedman RS
    Cancer Res; 1991 Aug; 51(16):4257-65. PubMed ID: 1868446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gains and losses of CD8, CD20 and CD56 expression in tumor stroma-infiltrating lymphocytes compared with tumor-associated lymphocytes from ascitic fluid and lymphocytes from tumor draining lymph nodes in serous papillary ovarian carcinoma patients.
    Papadopoulos N; Kotini A; Cheva A; Jivannakis T; Manavis J; Alexiadis G; Lambropoulou M; Vavetsis S; Tamiolakis D
    Eur J Gynaecol Oncol; 2002; 23(6):533-6. PubMed ID: 12556098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte subpopulations in malignant ascites of serous papillary ovarian adenocarcinoma. An immunocytochemical study.
    Guzman J; Hilgarth M; Bross KJ; Wiehle U; Ross A; Kresin V; Costabel U
    Acta Cytol; 1988; 32(6):811-5. PubMed ID: 2974226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in expression and function of signal transducing proteins in tumor-associated T and natural killer cells in ovarian carcinoma.
    Lai P; Rabinowich H; Crowley-Nowick PA; Bell MC; Mantovani G; Whiteside TL
    Biochem Soc Trans; 1997 May; 25(2):218S. PubMed ID: 9191262
    [No Abstract]   [Full Text] [Related]  

  • 11. Expression of cytokine genes or proteins and signaling molecules in lymphocytes associated with human ovarian carcinoma.
    Rabinowich H; Suminami Y; Reichert TE; Crowley-Nowick P; Bell M; Edwards R; Whiteside TL
    Int J Cancer; 1996 Nov; 68(3):276-84. PubMed ID: 8903466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of regulatory T cells, cytotoxic lymphocytes and dendritic cells in ovarian cancer patients before and after menopause.
    Surówka JA; Wertel I; Polak G; Okła K; Bilska M; Kotarski J
    Ginekol Pol; 2016; 87(1):11-8. PubMed ID: 27306463
    [No Abstract]   [Full Text] [Related]  

  • 13. The mucosal immunological network: compartmentalization of lymphocytes, natural killer cells, and mast cells.
    Bienenstock J; Befus AD; McDermott M; Mirski S; Rosenthal K; Tagliabue A
    Ann N Y Acad Sci; 1983 Jun; 409():164-70. PubMed ID: 6346987
    [No Abstract]   [Full Text] [Related]  

  • 14. Natural killer activity of human liver-derived lymphocytes in various liver diseases.
    Hata K; Van Thiel DH; Herberman RB; Whiteside TL
    Hepatology; 1991 Sep; 14(3):495-503. PubMed ID: 1874494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD103+ intraepithelial T cells in high-grade serous ovarian cancer are phenotypically diverse TCRαβ+ CD8αβ+ T cells that can be targeted for cancer immunotherapy.
    Komdeur FL; Wouters MC; Workel HH; Tijans AM; Terwindt AL; Brunekreeft KL; Plat A; Klip HG; Eggink FA; Leffers N; Helfrich W; Samplonius DF; Bremer E; Wisman GB; Daemen T; Duiker EW; Hollema H; Nijman HW; de Bruyn M
    Oncotarget; 2016 Nov; 7(46):75130-75144. PubMed ID: 27650547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human bone marrow and myeloid progenitors by interleukin 2-activated lymphocytes.
    Savary CA; Lotzová E
    Exp Hematol; 1990 Nov; 18(10):1083-9. PubMed ID: 2209762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraepithelial T cells and tumor proliferation: impact on the benefit from surgical cytoreduction in advanced serous ovarian cancer.
    Adams SF; Levine DA; Cadungog MG; Hammond R; Facciabene A; Olvera N; Rubin SC; Boyd J; Gimotty PA; Coukos G
    Cancer; 2009 Jul; 115(13):2891-902. PubMed ID: 19472394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between the neocortex and lymphocytes.
    Bizière K; Renoux G
    Clin Neuropharmacol; 1986; 9 Suppl 4():362-4. PubMed ID: 3494511
    [No Abstract]   [Full Text] [Related]  

  • 19. Expression of CD94/NKG2 subtypes on tumor-infiltrating lymphocytes in primary and metastatic melanoma.
    Vetter CS; Straten PT; Terheyden P; Zeuthen J; Bröcker EB; Becker JC
    J Invest Dermatol; 2000 May; 114(5):941-7. PubMed ID: 10771475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole body hyperthermia induces apoptosis in subpopulations of blood lymphocytes.
    Dieing A; Ahlers O; Kerner T; Wust P; Felix R; Löffel J; Riess H; Hildebrandt B
    Immunobiology; 2003; 207(4):265-73. PubMed ID: 12952349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.